Dotarem and Morphine drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Dotarem (gadoterate meglumine) and Morphine (morphine sulfate). Common drug interactions include bone pain among females and seizure among males.

The phase IV clinical study analyzes what interactions people have when they take Dotarem and Morphine. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Dotarem?

Dotarem has active ingredients of gadoterate meglumine. eHealthMe is studying from 2,749 Dotarem users. Check the latest studies of Dotarem.

What is Morphine?

Morphine has active ingredients of morphine sulfate. It is often used in pain. eHealthMe is studying from 182,913 Morphine users. Check the latest studies of Morphine.



On Jul, 23, 2026

24 people who take Dotarem and Morphine together, and have interactions are studied.

Dotarem and Morphine drug interactions.

What are the common drug interactions of Dotarem and Morphine, by gender? *:

female:

  1. Bone pain
  2. Bacteraemia (presence of bacteria in the blood)
  3. Device failure
  4. Hypoglycaemia (deficiency of glucose in the bloodstream)
  5. Hypotension (abnormally low blood pressure)
  6. Small intestinal obstruction (blockage in small intestine)
  7. Anaphylactic reaction (serious allergic reaction)
  8. Nausea (feeling of having an urge to vomit)
  9. Vomiting
  10. Abdominal pain

male:

  1. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  2. Adverse event
  3. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  4. Cytokine storm (over-protective immune response that can actually be fatal)
  5. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  6. Haematuria (presence of blood in urine)
  7. Hyperkalaemia (damage to or disease of the kidney)
  8. Hyperphosphataemia (electrolyte disturbance in which there is an abnormally elevated level of phosphate in the blood)
  9. Hypocalcaemia (levels of calcium in blood serum are abnormally low)
  10. Hypotension (abnormally low blood pressure)

What are the common drug interactions of Dotarem and Morphine, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Bone pain
  2. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  3. Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
  4. Blood creatinine increased
  5. Blood lactic acid increased
  6. Blood urea increased
  7. Bone marrow failure
  8. Bradycardia (abnormally slow heart action)
  9. Cytokine release syndrome (immediate complication occurring with the use of anti-t cell antibody infusions)
  10. Cytokine storm (over-protective immune response that can actually be fatal)

20-29:

n/a

30-39:

  1. Nausea (feeling of having an urge to vomit)
  2. Seizure (abnormal excessive or synchronous neuronal activity in the brain)
  3. Vomiting

40-49:

n/a

50-59:

n/a

60+:

  1. Bacteraemia (presence of bacteria in the blood)
  2. Device failure
  3. Nausea (feeling of having an urge to vomit)
  4. Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
  5. Renal failure (kidney dysfunction)
  6. Vomiting
  7. Hypoglycaemia (deficiency of glucose in the bloodstream)
  8. Hypotension (abnormally low blood pressure)
  9. Small intestinal obstruction (blockage in small intestine)
  10. Anaphylactic reaction (serious allergic reaction)

What are the existing conditions these people have? *

  1. Constipation: 15 people, 62.50%
  2. Nausea (feeling of having an urge to vomit): 12 people, 50.00%
  3. Nausea And Vomiting: 12 people, 50.00%
  4. Stress And Anxiety: 10 people, 41.67%
  5. Pain In Extremity: 9 people, 37.50%
  6. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 9 people, 37.50%
  7. Birth Control: 9 people, 37.50%
  8. Oral Herpes (viral infection of mouth): 9 people, 37.50%
  9. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 8 people, 33.33%
  10. Nervous System Disorder (a general class of medical conditions affecting the nervous system): 5 people, 20.83%

* Approximation only. Some reports may have incomplete information.

Do you take Dotarem and Morphine?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Dotarem and Morphine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Dotarem:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Morphine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Dotarem and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Morphine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on gadoterate meglumine and morphine sulfate (the active ingredients of Dotarem and Morphine, respectively), and Dotarem and Morphine (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: